Effects of Ventilator Hyperinflation Versus Vibrocompression in Mechanically Ventilated Patients
1 other identifier
interventional
81
1 country
1
Brief Summary
The aim of the current study is to compare the effects of ventilator hyperinflation and vibrocompression on lung compliance in mechanically ventilated patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFebruary 7, 2025
February 1, 2025
3 months
January 17, 2025
February 5, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Static Compliance
Static compliance (ml/cmH2O).
Before, after treatment at Day 1 and Day 4
Airway Resistance
Airway Resistance (cmH2O/l/s).
Before, after treatment at Day 1 and Day 4
Sputum Volume in ml
Airway suction will be carried out immediately after treatment or during treatment if indicated and will be measured as sputum volume in ml.
Immediately after treatment at Day 1 and Day 4
Peak Expiratory Flow and Peak Inspiratory Flow
Peak Expiratory Flow (l/min) and Peak Inspiratory Flow (l/min)
Before, after treatment at Day 1 and Day 4
Secondary Outcomes (1)
Oxygen Saturation (SPO2)
Before, after treatment at Day 1 and Day 4
Study Arms (3)
Study Group (A)
ACTIVE COMPARATORThe patients in the study group (A) will be treated with ventilator hyperinflation in addition to a traditional chest physical therapy program (percussion, postural drainage, and suction) for 4 successive sessions at a rate of one session per day.
Study Group (B)
ACTIVE COMPARATORThe patients in the study group (B) will be treated with vibrocompression in addition to a traditional chest physical therapy program (percussion, postural drainage, and suction) for 4 successive sessions at a rate of one session per day.
Control Group (C)
ACTIVE COMPARATORThe patients in the control group (C) will be treated with a traditional chest physical therapy program (percussion, postural drainage, and suction) for 4 successive sessions at a rate of one session per day.
Interventions
In ventilator hyperinflation volume control mode, the ventilator will be set to eight breaths per minute, and the tidal volume will be increased to deliver hyperinflation breaths that are 15 ml/kg, as will be calculated using the predicted body weight. Tidal volume will be increased in 150-ml increments until a peak airway pressure of 40 cmH2O is achieved. Once this pressure is reached, eight mechanical breaths will be delivered to the patient. After this, the ventilator will be reset to pretreatment variables, and the patient will be rested for 30 s. The sequence will be repeated. The treatment will consist of five sets of eight ventilator hyperinflation breaths.
Vibrocompression will be performed by the physical therapist to produce vibration and will be combined with compression of the patient's chest in the expiratory phase. Every vibrocompression will be interrupted at the end of each expiratory phase to allow free inspiration.
Percussion, Postural Drainage, and Suction
Eligibility Criteria
You may qualify if:
- Eighty-one mechanically ventilated patients more than 48 hours up to 7 days
- Their ages range from 35 to 55 years old.
- Medical stability (mean arterial pressure \> 60 \< 110, systolic blood pressure \> 80, diastolic blood pressure \> 60, fraction of inspired oxygen \< 60, positive end expiratory pressure (PEEP) \<10)
You may not qualify if:
- Patients will be excluded if they have the following conditions or diseases:
- Unstable hemodynamics
- Fraction of inspired oxygen (FiO2) ≥ 0.6
- PEEP ≥ 10 cmH2O
- undrained pneumothorax and hemothorax or subcutaneous emphysema
- Pulmonary pathology (e.g., acute respiratory distress syndrome, exacerbation of chronic obstructive pulmonary disease, and acute pulmonary edema)
- Unstable neurological problems (raised intracranial pressure).
- Lung Cancer
- Recent/unhealed rib fracture
- Any disease obstructs our study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Kasr AL Ainy
Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Nadia H Mohamed, MSc
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Therapist, MSc in Physical Therapy, Cairo University
Study Record Dates
First Submitted
January 17, 2025
First Posted
January 24, 2025
Study Start
February 1, 2025
Primary Completion
May 1, 2025
Study Completion
May 1, 2025
Last Updated
February 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share